Pediatric systemic lupus erythematosus and human parvovirus B19 infection by Bélien-Pallet, V et al.
POSTER PRESENTATION Open Access
Pediatric systemic lupus erythematosus and
human parvovirus B19 infection
V Bélien-Pallet
1, S Sauvion
1, R Salomon
2, P Quartier
3, B Bader-Meunier
3*
From 18th Pediatric Rheumatology European Society (PReS) Congress
Bruges, Belgium. 14-18 September 2011
Aim
To describe presentation and course of paediatric
systemic lupus erythematosus (pSLE), associated with
Parvovirus B19(PB19) primo-infection.
Methods
Retrospective monocentric study of patients with pSLE,
defined according to ARA criteria, diagnosed before
16 years old, and associated with PB19 primo-infection,
defined by the presence of PB19 IgM antibodies and PB19
DNA detected by PCR in blood and/or in tissue.
Results
3 girls aged from 8 years to 15 years 8 months have been
included. PB19 infection was present at diagnosis in all
patients. Maternal history of autoimmune diseases was
noted in a consanguineous family. Clinical manifestations
at diagnosis were fever(3), arthritis/arthralgia (3), skin rash
(1), grade IV glomerulonephritis (1), interstitial pneumonia
(1), cerebral vasculitis (1), pericarditis/pleurisy (1), adeno-
pathy (2), hepatomegaly/splenomegaly (1). Aregenerative
anaemia requiring packed red blood cell transfusion was
present in all patients. AAN (3), anti –DNA (3), anti-SSa
(1), anti-SSb (1), anti-phospholipid (1), anti-platelet (2),
rheumatoid factor (2), pANCA (1), anti-actin (1) antibo-
dies were found. PB19 PCR was positive in blood (3), bone
marrow (2) and kidney (1). Corticosteroids have been
initiated for the 3 patients, in association with one or
more immunosuppressive therapies. A sustained remission
has been observed in 2 patients after a follow-up of 4 years
and 1 year 8 months off-therapy respectively. A severe
course with joint damages, recurrent pericarditis and gra-
deIV glomerulonephritis, associated with persistent
infection by PB19, has been observed in the third case
(family autoimmunity history).
Conclusion
PB19 infection-associated-pSLE may evolve either to a
persistent remission off-therapy or to a severe pSLE. It
should be considered in patient with pSLE associated
with a severe aregenerative anemia.
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